Less than two years after buying Chinese biotech Gracell for its cell therapy platform, AstraZeneca has reported encouraging clinical results with the lead CAR-T from the deal, GC012F (now AZD0120), ...

All rather splendid, but it doesn't end there. Blurbs even coded in a full-on battle system. Simply aim your gun at a fellow trainer and hit go (this is how it also works for Ash Ketchum, probably), ...